from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1399c/nlhH

LFCtreatmentdescriptionclass of inhibitor

-1.123

Amikacinug/mL Amikacintranslation

0.173

Cap5-10ug/mL Capreomycintranslation

-0.476

Rox10-50 ug/mL Roxithromycintranslation

-0.030

SM2-5 ug/mL Streptomycintranslation

-1.528

Tet5-10 ug/mL Tetracyclinetranslation

0.101

Rif0.2-5ug/mL Rifampicintranscription

-0.589

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.760

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.885

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.157

CPZ10-50 ug/mL Chlorpromazinerespiration

0.574

Clofazimine10-13 ug/mL Clofaziminerespiration

0.811

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.700

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.798

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.353

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.766

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.292

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.180

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.636

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.209

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.183

KCN5-20 ug/mL Potassium cyaniderespiration

0.080

NaN30.2-2 mM Sodium aziderespiration

0.276

Nigericin50 uM Nigericinrespiration

-0.068

TRC10-150 ug/mL Triclosanrespiration

-0.492

TRZ10-25 ug/mL Thioridazinerespiration

-1.158

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.754

menadione6-10 ug/mL Menadionerespiration

0.167

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.340

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.043

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.493

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.771

NRP_1Non-replicating persistence stage 1dosRassociated

-0.107

Amp0.2mg/mL AmpicillincellWall

0.266

Cephalexin20-100 ug/mL CephalexincellWall

0.320

Cerulenin0.32-5 ug/mL CerulenincellWall

0.162

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.317

EMB10-20 ug/mL EthambutolcellWall

-0.078

Eta12-40 ug/mL EthionamidecellWall

-0.469

INH0.2-0.4 ug/mL IsoniazidcellWall

0.135

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.763

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.147

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.241

BZA0.12 mg/mL BenzamidearomaticAmides

0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.018

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.616

H2O24 mM hydrogen peroxideDNAdamaging

-0.263

Levo10 ug/mL LevofloxacinDNAdamaging

-0.373

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.746

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.131

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.048

UVUV-irradiationDNAdamaging

3.568

ARP41-4 ug/mL Antitubercular compound ARP4?

0.768

Antimycin12.5-50 ug/mL Antimycin A?

0.275

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.022

PA_110-50 ug/mL Antitubercular compound PA-1?

0.809

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.736

PA8240.2-2 ug/mL PA-824?

0.248

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.262

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.918

Verapamil50 uM Verapamil?

0.223

mercaptoethanol2 mM 2-Mercaptoethanol?

1.157

methoxatin10-20 ug/mL Methoxatin?